Send to

Choose Destination
Mol Autism. 2013 Oct 3;4(1):36. doi: 10.1186/2040-2392-4-36.

SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs).

Author information

Departments of Genetics and Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA.
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zilkha Neurogenetic Institute and Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA.
Department of Molecular Biology, Cell Biology and Biochemistry; and Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA.
IMHRO/Staglin Assistant Professor, Department of Psychiatry, Institute for Human Genetics, Center for Neurobiology and Psychiatry, UCSF, San Francisco, CA, USA.
MindSpec Inc., 8280 Greensboro Drive, Suite 150, McLean, VA, USA.
Department of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Simons Foundation Autism Research Initiative, New York, NY, USA.
Contributed equally


New technologies enabling genome-wide interrogation have led to a large and rapidly growing number of autism spectrum disorder (ASD) candidate genes. Although encouraging, the volume and complexity of these data make it challenging for scientists, particularly non-geneticists, to comprehensively evaluate available evidence for individual genes. Described here is the Gene Scoring module within SFARI Gene 2.0 (, a platform developed to enable systematic community driven assessment of genetic evidence for individual genes with regard to ASD.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center